Familial Amyloid Polyneuropathy Market
1 Introduction to Research & Analysis Reports
1.1 Familial Amyloid Polyneuropathy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Familial Amyloid Polyneuropathy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Familial Amyloid Polyneuropathy Overall Market Size
2.1 Global Familial Amyloid Polyneuropathy Market Size: 2021 VS 2028
2.2 Global Familial Amyloid Polyneuropathy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Familial Amyloid Polyneuropathy Players in Global Market
3.2 Top Global Familial Amyloid Polyneuropathy Companies Ranked by Revenue
3.3 Global Familial Amyloid Polyneuropathy Revenue by Companies
3.4 Top 3 and Top 5 Familial Amyloid Polyneuropathy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Familial Amyloid Polyneuropathy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Familial Amyloid Polyneuropathy Players in Global Market
3.6.1 List of Global Tier 1 Familial Amyloid Polyneuropathy Companies
3.6.2 List of Global Tier 2 and Tier 3 Familial Amyloid Polyneuropathy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Familial Amyloid Polyneuropathy Market Size Markets, 2021 & 2028
4.1.2 FAP-I
4.1.3 FAP-II
4.1.4 FAP-III
4.1.5 FAP-IV
4.2 By Type - Global Familial Amyloid Polyneuropathy Revenue & Forecasts
4.2.1 By Type - Global Familial Amyloid Polyneuropathy Revenue, 2017-2022
4.2.2 By Type - Global Familial Amyloid Polyneuropathy Revenue, 2023-2028
4.2.3 By Type - Global Familial Amyloid Polyneuropathy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Familial Amyloid Polyneuropathy Market Size, 2021 & 2028
5.1.2 Hospitals and Clinics
5.1.3 Others
5.2 By Application - Global Familial Amyloid Polyneuropathy Revenue & Forecasts
5.2.1 By Application - Global Familial Amyloid Polyneuropathy Revenue, 2017-2022
5.2.2 By Application - Global Familial Amyloid Polyneuropathy Revenue, 2023-2028
5.2.3 By Application - Global Familial Amyloid Polyneuropathy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Familial Amyloid Polyneuropathy Market Size, 2021 & 2028
6.2 By Region - Global Familial Amyloid Polyneuropathy Revenue & Forecasts
6.2.1 By Region - Global Familial Amyloid Polyneuropathy Revenue, 2017-2022
6.2.2 By Region - Global Familial Amyloid Polyneuropathy Revenue, 2023-2028
6.2.3 By Region - Global Familial Amyloid Polyneuropathy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Familial Amyloid Polyneuropathy Revenue, 2017-2028
6.3.2 US Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.3.3 Canada Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.3.4 Mexico Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Familial Amyloid Polyneuropathy Revenue, 2017-2028
6.4.2 Germany Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.4.3 France Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.4.4 U.K. Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.4.5 Italy Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.4.6 Russia Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.4.7 Nordic Countries Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.4.8 Benelux Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Familial Amyloid Polyneuropathy Revenue, 2017-2028
6.5.2 China Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.5.3 Japan Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.5.4 South Korea Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.5.5 Southeast Asia Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.5.6 India Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Familial Amyloid Polyneuropathy Revenue, 2017-2028
6.6.2 Brazil Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.6.3 Argentina Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Familial Amyloid Polyneuropathy Revenue, 2017-2028
6.7.2 Turkey Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.7.3 Israel Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.7.4 Saudi Arabia Familial Amyloid Polyneuropathy Market Size, 2017-2028
6.7.5 UAE Familial Amyloid Polyneuropathy Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Familial Amyloid Polyneuropathy Major Product Offerings
7.1.4 Pfizer Familial Amyloid Polyneuropathy Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Familial Amyloid Polyneuropathy Major Product Offerings
7.2.4 GSK Familial Amyloid Polyneuropathy Revenue in Global Market (2017-2022)
7.2.5 GSK Key News
7.3 Ionis
7.3.1 Ionis Corporate Summary
7.3.2 Ionis Business Overview
7.3.3 Ionis Familial Amyloid Polyneuropathy Major Product Offerings
7.3.4 Ionis Familial Amyloid Polyneuropathy Revenue in Global Market (2017-2022)
7.3.5 Ionis Key News
7.4 Alnylam
7.4.1 Alnylam Corporate Summary
7.4.2 Alnylam Business Overview
7.4.3 Alnylam Familial Amyloid Polyneuropathy Major Product Offerings
7.4.4 Alnylam Familial Amyloid Polyneuropathy Revenue in Global Market (2017-2022)
7.4.5 Alnylam Key News
7.5 Corino Therapeutics
7.5.1 Corino Therapeutics Corporate Summary
7.5.2 Corino Therapeutics Business Overview
7.5.3 Corino Therapeutics Familial Amyloid Polyneuropathy Major Product Offerings
7.5.4 Corino Therapeutics Familial Amyloid Polyneuropathy Revenue in Global Market (2017-2022)
7.5.5 Corino Therapeutics Key News
7.6 Proclara Bioscience
7.6.1 Proclara Bioscience Corporate Summary
7.6.2 Proclara Bioscience Business Overview
7.6.3 Proclara Bioscience Familial Amyloid Polyneuropathy Major Product Offerings
7.6.4 Proclara Bioscience Familial Amyloid Polyneuropathy Revenue in Global Market (2017-2022)
7.6.5 Proclara Bioscience Key News
7.7 Arcturus Therapeutics
7.7.1 Arcturus Therapeutics Corporate Summary
7.7.2 Arcturus Therapeutics Business Overview
7.7.3 Arcturus Therapeutics Familial Amyloid Polyneuropathy Major Product Offerings
7.7.4 Arcturus Therapeutics Familial Amyloid Polyneuropathy Revenue in Global Market (2017-2022)
7.7.5 Arcturus Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Familial Amyloid Polyneuropathy Market Opportunities & Trends in Global Market
Table 2. Familial Amyloid Polyneuropathy Market Drivers in Global Market
Table 3. Familial Amyloid Polyneuropathy Market Restraints in Global Market
Table 4. Key Players of Familial Amyloid Polyneuropathy in Global Market
Table 5. Top Familial Amyloid Polyneuropathy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Familial Amyloid Polyneuropathy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Familial Amyloid Polyneuropathy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Familial Amyloid Polyneuropathy Product Type
Table 9. List of Global Tier 1 Familial Amyloid Polyneuropathy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Familial Amyloid Polyneuropathy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Familial Amyloid Polyneuropathy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Familial Amyloid Polyneuropathy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Familial Amyloid Polyneuropathy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Familial Amyloid Polyneuropathy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Familial Amyloid Polyneuropathy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Familial Amyloid Polyneuropathy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Familial Amyloid Polyneuropathy Product Offerings
Table 32. Pfizer Familial Amyloid Polyneuropathy Revenue (US$, Mn), (2017-2022)
Table 33. GSK Corporate Summary
Table 34. GSK Familial Amyloid Polyneuropathy Product Offerings
Table 35. GSK Familial Amyloid Polyneuropathy Revenue (US$, Mn), (2017-2022)
Table 36. Ionis Corporate Summary
Table 37. Ionis Familial Amyloid Polyneuropathy Product Offerings
Table 38. Ionis Familial Amyloid Polyneuropathy Revenue (US$, Mn), (2017-2022)
Table 39. Alnylam Corporate Summary
Table 40. Alnylam Familial Amyloid Polyneuropathy Product Offerings
Table 41. Alnylam Familial Amyloid Polyneuropathy Revenue (US$, Mn), (2017-2022)
Table 42. Corino Therapeutics Corporate Summary
Table 43. Corino Therapeutics Familial Amyloid Polyneuropathy Product Offerings
Table 44. Corino Therapeutics Familial Amyloid Polyneuropathy Revenue (US$, Mn), (2017-2022)
Table 45. Proclara Bioscience Corporate Summary
Table 46. Proclara Bioscience Familial Amyloid Polyneuropathy Product Offerings
Table 47. Proclara Bioscience Familial Amyloid Polyneuropathy Revenue (US$, Mn), (2017-2022)
Table 48. Arcturus Therapeutics Corporate Summary
Table 49. Arcturus Therapeutics Familial Amyloid Polyneuropathy Product Offerings
Table 50. Arcturus Therapeutics Familial Amyloid Polyneuropathy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Familial Amyloid Polyneuropathy Segment by Type in 2021
Figure 2. Familial Amyloid Polyneuropathy Segment by Application in 2021
Figure 3. Global Familial Amyloid Polyneuropathy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Familial Amyloid Polyneuropathy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Familial Amyloid Polyneuropathy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Familial Amyloid Polyneuropathy Revenue in 2021
Figure 8. By Type - Global Familial Amyloid Polyneuropathy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Familial Amyloid Polyneuropathy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Familial Amyloid Polyneuropathy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Familial Amyloid Polyneuropathy Revenue Market Share, 2017-2028
Figure 12. US Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Familial Amyloid Polyneuropathy Revenue Market Share, 2017-2028
Figure 16. Germany Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 17. France Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Familial Amyloid Polyneuropathy Revenue Market Share, 2017-2028
Figure 24. China Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 28. India Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Familial Amyloid Polyneuropathy Revenue Market Share, 2017-2028
Figure 30. Brazil Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Familial Amyloid Polyneuropathy Revenue Market Share, 2017-2028
Figure 33. Turkey Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Familial Amyloid Polyneuropathy Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Familial Amyloid Polyneuropathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GSK Familial Amyloid Polyneuropathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Ionis Familial Amyloid Polyneuropathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Alnylam Familial Amyloid Polyneuropathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Corino Therapeutics Familial Amyloid Polyneuropathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Proclara Bioscience Familial Amyloid Polyneuropathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Arcturus Therapeutics Familial Amyloid Polyneuropathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
